Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)

Journal of Biological Chemistry

Volumn 289, Issue 17, 2014, Pages 11897-11905

  Herva, Maria Eugenia ^a   Zibaee, Shahin ^b   Fraser, Graham ^b   Barker, Roger A ^a   Goedert, Michel ^b   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLIFICATION; CELL CULTURE; PROTEINS;

FIBRIL FORMATION; HIGH THROUGHPUT SCREENING; IN-VITRO; PROTEIN MISFOLDING; SYNUCLEIN;

GLYCOPROTEINS;

ACETYLSALICYLIC ACID; ALPHA SYNUCLEIN; ANTIAMYLOID AGENT; CONGO RED; CURCUMIN; IBUPROFEN; LACMOID ACID; MEPACRINE; PARACETAMOL; PRION PROTEIN; PROTEIN ANTIBODY; PROTEINASE K; RESVERATROL; TANNIN; UNCLASSIFIED DRUG;

ALPHA SYNUCLEINOPATHY; ARTICLE; CELL CULTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ELECTRON MICROSCOPY; HIGH THROUGHPUT SCREENING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEINOSIS;

AMYLOID; CELL THERAPY; DRUG SCREENING; PMCA; PROTEIN AGGREGATION; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; AMYLOID; CELL LINE; HUMANS; PROTEIN FOLDING; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 84899422309     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.542340     Document Type: Article

References (43)

1. Goedert, M., Spillantini, M. G., Del Tredici, K., and Braak, H. (2013) 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13-24
2. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) α-synuclein in Lewy bodies. Nature 388, 839-840
3. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473 (Pubitemid 28249037)
4. Vekrellis, K., Xilouri, M., Emmanouilidou, E., Rideout, H. J., and Stefanis, L. (2011) Pathological roles of α-synuclein in neurological disorders. Lancet Neurol. 10, 1015-1025
5. Houlden, H., and Singleton, A. B. (2012) The genetics and neuropathology of Parkinson's disease. Acta Neuropathol. 124, 325-338
6. Singleton, A. B., Farrer, M. J., and Bonifati, V. (2013) The genetics of Parkinson's disease: progress and therapeutic implications. Mov. Disord. 28, 14-23
7. Uversky, V. N., and Eliezer, D. (2009) Biophysics of Parkinson's disease: structure and aggregation of α-synuclein. Curr. Protein Pept. Sci. 10, 483-499
8. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (Pubitemid 12089840)
9. Prusiner, S. B., Scott, M. R., DeArmond, S. J., and Cohen, F. E. (1998) Prion protein biology. Cell 93, 337-348 (Pubitemid 28232079)
10. Miake, H., Mizusawa, H., Iwatsubo, T., and Hasegawa, M. (2002) Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277, 19213-19219 (Pubitemid 34952489)
11. El-Agnaf, O. M., Jakes, R., Curran, M. D., and Wallace, A. (1998) Effects of the mutations Ala-30 to Pro and Ala-53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440, 67-70 (Pubitemid 28558737)
12. Saborio, G. P., Permanne, B., and Soto, C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (Pubitemid 32588105)
13. Jakes, R., Spillantini, M. G., and Goedert, M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32 (Pubitemid 24154659)
14. Jakes, R., Crowther, R. A., Lee, V. M., Trojanowski, J. Q., Iwatsubo, T., and Goedert, M. (1999) Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci. Lett. 269, 13-16 (Pubitemid 29305690)
15. Tofaris, G. K., Layfield, R., and Spillantini, M. G. (2001) α-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509, 22-26 (Pubitemid 33153074)
16. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 177, 244-249 (Pubitemid 19088253)
17. Rudyk, H., Vasiljevic, S., Hennion, R. M., Birkett, C. R., Hope, J., and Gilbert, I. H. (2000) Screening Congo red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J. Gen. Virol. 81, 1155-1164 (Pubitemid 30189659)
18. Maltsev, A. S., Grishaev, A., and Bax, A. (2012) Monomeric α-synuclein binds Congo red micelles in a disordered manner. Biochemistry 51, 631-642
19. Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., and Galvin, J. E. (2008) Curcumin inhibits aggregation of α-synuclein. Acta Neuropathol. 115, 479-489
20. Doh-Ura, K., Iwaki, T., and Caughey, B. (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74, 4894-4897 (Pubitemid 30237920)
21. O'Hare, E., Elliott, J. J., Hobson, P., Spanswick, D., and Kim, E. M. (2010) Behavioural deterioration induced by intrahippocampal NAC61-95 injections and attenuation with ibuprofen. Behav. Brain Res. 208, 274-277
22. Locke, C. J., Fox, S. A., Caldwell, G. A., and Caldwell, K. A. (2008) Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease. Neurosci. Lett. 439, 129-133
23. Hirohata, M., Ono, K., and Yamada, M. (2008) Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds. Curr. Pharm. Des. 14, 3280-3294
24. Lendel, C., Bertoncini, C. W., Cremades, N., Waudby, C. A, Vendruscolo, M., Dobson, C. M., Schenk, D., Christodoulou, J., and Toth, G. (2009) On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions ofα-synuclein with Congo red and lacmoid. Biochemistry 48, 8322-8334
25. Ahn, J. S., Lee, J. H., Kim, J. H., and Paik, S. R. (2007) Novel method for quantitative determination of amyloid fibrils of α-synuclein and amyloid β/A4 protein by using resveratrol. Anal. Biochem. 367, 259-265 (Pubitemid 47001931)
26. Ono, K., Hirohata, M., and Yamada, M. (2007) Anti-fibrillogenic and fibril- destabilizing activities of anti-Parkinsonian agents for α-synuclein fibrils in vitro. J. Neurosci. Res. 85, 1547-1557 (Pubitemid 46724398)
27. Caruana, M., Högen, T., Levin, J., Hillmer, A., Giese, A., and Vassallo, N. (2011) Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 585, 1113-1120
28. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715
29. Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., and Bieschke, J. (2011) Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils. Biochemistry 50, 10624-10636
30. Pienaar, I. S., Burn, D., Morris, C., and Dexter, D. (2012) Synaptic protein alterations in Parkinson's disease. Mol. Neurobiol. 45, 126-143
31. Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., and Lee, S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. U.S.A. 106, 13010-13015
32. Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., and Lee, V. M. (2009) Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20051-20056
33. Volpicelli-Daley, L. A, Luk, K. C., Patel, T. P., Tanik, S. a, Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., and Lee, V. M. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57-71
34. Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J. Q., and Lee, V. M. (2012) Pathological α-synuclein transmission initiates Parkinson- like neurodegeneration in nontransgenic mice. Science 338, 949-953
35. Freundt, E. C., Maynard, N., Clancy, E. K., Roy, S., Bousset, L., Sourigues, Y., Covert, M., Melki, R., Kirkegaard, K., and Brahic, M. (2012) Neuronto- neuron transmission of α-synuclein fibrils through axonal transport. Ann. Neurol. 72, 517-524
36. Roostaee, A., Beaudoin, S., Staskevicius, A., and Roucou, X. (2013) Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization. Mol. Neurodegener. 8, 5
37. Campioni, S., Carret, G., Jordens, S., Nicoud, L., Mezzenga, R., and Riek, R. (2014) The presence of an air-water interface affects formation and elongation of α-synuclein fibrils. J. Am. Chem. Soc. 136, 2866-2875
38. Sahay, S., Anoop, A., Krishnamoorthy, G., and Maji, S. K. (2014) Sitespecific fluorescence dynamics of α-synuclein fibrils using time-resolved fluorescence studies: effect of familial Parkinson's disease-associated mutations. Biochemistry 53, 807-809
39. Yamin, G., Munishkina, L. A., Karymov, M. A., Lyubchenko, Y. L., Uversky, V. N., and Fink, A. L. (2005) Forcing nonamyloidogenicα-synuclein to fibrillate. Biochemistry 44, 9096-9107
40. Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., and Lee, V. M. (2013) Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103-117
41. Samii, A., Etminan, M., Wiens, M. O., and Jafari, S. (2009) NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 26, 769-779
42. Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., and Ben- Shlomo, Y. (2011) Non-steroidal anti-inflammatory drugs as diseasemodifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database Syst. Rev. CD008454
43. Pinotsi, D., Buell, A. K., Dobson, C. M., Kaminski Schierle, G. S., and Kaminski, C. F. (2013) A label-free, quantitative assay of amyloid fibril growth based on intrinsic fluorescence. ChemBiochem 14, 846-850